SCHEMBL24809404

SCHEMBL24809404

O=C(NCCc1ccccc1)n1cnc(-c2ccccc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
HIF1A Q16665 2/20 0.47
TAAR1 Q96RJ0 1/20 0.46
FAAH O00519 2/20 0.46
P2RX4 Q99571 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HPGD P15428 1/20 0.46
KDM4E B2RXH2 2/20 0.45
KDM5A P29375 1/20 0.45
KDM5C P41229 1/20 0.45
KDM5B Q9UGL1 1/20 0.45
ASAH1 Q13510 1/20 0.45
MAPT P10636 4/20 0.45
RAB9A P51151 2/20 0.45
CYP1A2 P05177 1/20 0.45
BCHE P06276 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24810703 0.92 RAB9A (0.51) ALDH1A1HIF1AP2RX4SMN1; SMN2KDM4E
SCHEMBL24809675 0.92 ASAH1 (0.50) FAAHHPGDASAH1RAB9A
SCHEMBL24811030 0.90 CYP2C9 (0.54) ALDH1A1HIF1ASMN1; SMN2ASAH1MAPT
SCHEMBL29817737 0.90 CYP2C9 (0.54) ALDH1A1HIF1ASMN1; SMN2ASAH1MAPT
SCHEMBL23132278 0.87 MCHR1 (0.45) ALDH1A1HIF1ATAAR1FAAHP2RX4
SCHEMBL24810560 0.87 HIF1A (0.46) ALDH1A1HIF1AFAAHP2RX4SMN1; SMN2
SCHEMBL24809408 0.87 HIF1A (0.46) ALDH1A1HIF1ASMN1; SMN2HPGDKDM4E
SCHEMBL24809783 0.86 FAAH (0.43) ALDH1A1HIF1ATAAR1FAAHP2RX4
SCHEMBL24809403 0.86 ASAH1 (0.50) ALDH1A1P2RX4SMN1; SMN2HPGDKDM4E
SCHEMBL29817593 0.86 ASAH1 (0.50) ALDH1A1P2RX4SMN1; SMN2HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411388-A1 SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS BIAL R&D INVEST S A (PT) 2022-12-29 US disclosed
EP-4031531-A1 SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Bial-R&D Investments, S.A. (PT) 2022-07-27 EP disclosed
CN-114787135-A Substituted imidazole carboxamides and their use in the treatment of medical disorders 比亚尔R&D投资股份公司 2022-07-22 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411388-A1 SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS GBA1, GAA, CLN6 ALDH1A1 1398/4885HIF1A 1983/4885TAAR1 2390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.